Herbas VPB

Print
EN | LT
LT - Antikūnai prieš CD3, bispecifinės antigenus surišančios molekulės, kurios suriša CD3 ir CD20, ir jų panaudojimas
EN - ANTI-CD3 ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/00 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
A61P 35/02 (2006.01)
A61P 37/04 (2006.01)
European patent
(11) Number of the document 2897981
(13) Kind of document T
(96) European patent application number 13773476.0
Date of filing the European patent application 2013-09-19
(97) Date of publication of the European application 2015-07-29
(45) Date of publication and mention of the grant of the patent 2023-06-07
(46) Date of publication of the claims translation 2023-07-10
PCT application
(86) Number PCT/US2013/060511
Date 2013-09-19
PCT application publication
(87) Number WO 2014/047231
Date 2014-03-27
Priority applications
(30) Number Date Country code
201261704029 P 2012-09-21 US
201361753461 P 2013-01-17 US
201361763110 P 2013-02-11 US
201361827098 P 2013-05-24 US
Inventors
(72)
SMITH, Eric , US
PAPADOPOULOS, Nicholas, J. , US
Grantee
(73) Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Antikūnai prieš CD3, bispecifinės antigenus surišančios molekulės, kurios suriša CD3 ir CD20, ir jų panaudojimas
  ANTI-CD3 ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF
Last renewal fee
Payment date Validity (years) Amount
2024-08-20 12 289.00 EUR
Next renewal fee
2025-09-19